Related Articles
Prognostic analysis of triple-negative breast cancer patients treated with adjuvant chemotherapy of fluorouracil, epirubicin and cyclophosphamide
Survivin, Ki‑67 and tumor grade as predictors of response to docetaxel‑based neoadjuvant chemotherapy in locally advanced breast cancer
Phase II study of neoadjuvant anthracycline combined with nanoparticle albumin‑bound paclitaxel for human epidermal growth factor receptor 2‑negative breast cancer
Comparison of adjuvant ED and EC-D regimens in operable breast invasive ductal carcinoma
Real‑world data indicated that neoadjuvant chemotherapy alone was associated with a higher risk of tumor recurrence in high‑risk breast cancer subgroup patients